Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation.
Indian Heart J
; 72(4): 306-308, 2020.
Article
em En
| MEDLINE
| ID: mdl-32861390
ABSTRACT
The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen consisting of sucralfate, proton-pump inhibitor and colchicine. Patients were followed and assessed at baseline, up until 6th month following the procedures.Among 115 patients who were included, 5 patients (4.3%) reported gastrointestinal symptoms at follow-up. No complications were diagnosed during the follow-up. In conclusion, the HPSD along with prophylactic regimen has been associated with low incidence of gastrointestinal adverse events.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrilação Atrial
/
Sucralfato
/
Colchicina
/
Ablação por Cateter
/
Inibidores da Bomba de Prótons
/
Gastroenteropatias
/
Átrios do Coração
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Indian Heart J
Ano de publicação:
2020
Tipo de documento:
Article